Climb Bio, Inc. CLYM Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Climb Bio, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Climb Bio, Inc.'s accrued expenses?
- Climb Bio, Inc. (CLYM) reported accrued expenses of $2.95M in Q1 2026.
- How has Climb Bio, Inc.'s accrued expenses changed year-over-year?
- Climb Bio, Inc.'s accrued expenses decreased by 51.7% year-over-year, from $6.1M to $2.95M.
- What is the long-term trend for Climb Bio, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Climb Bio, Inc.'s accrued expenses has grown at a 29.6% compound annual growth rate (CAGR), from $1.22M to $4.46M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.